(주)플럼라인생명과학

{
  "address": "서울 서초구",
  "ceo_name": "KIM ANTHONY KYUNG TAE",
  "certificate": [
    {
      "cert_number": "20150300072",
      "changes": "",
      "disclosure_date": "2015-03-26",
      "first_cert_date": "2015-03-26",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2015-03-26 ~ 2017-03-25"
    },
    {
      "cert_number": "20170300105",
      "changes": "",
      "disclosure_date": "2017-03-02",
      "first_cert_date": "2015-03-26",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2017-03-26 ~ 2019-03-25"
    },
    {
      "cert_number": "20200116379",
      "changes": "",
      "disclosure_date": "2020-12-21",
      "first_cert_date": "2015-03-26",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-12-21 ~ 2022-12-20"
    },
    {
      "cert_number": "20221221010003",
      "changes": "",
      "disclosure_date": "2022-12-21",
      "first_cert_date": "2015-03-26",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2022-12-21 ~ 2025-12-20"
    },
    {
      "cert_number": "20251203010012",
      "changes": "",
      "disclosure_date": "2025-12-03",
      "first_cert_date": "2015-03-26",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2025-12-21 ~ 2028-12-20"
    }
  ],
  "company_name": "(주)플럼라인생명과학",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 1643825000,
      "cost_of_sales": 0,
      "current_assets": 308124000,
      "current_liabilities": 3486435000,
      "gross_profit": 0,
      "net_income": -1761416000,
      "net_income_bs": -1761415000,
      "non_current_assets": 1167903000,
      "non_current_liabilities": 929507000,
      "non_operating_expenses": 330465000,
      "non_operating_income": 5095000,
      "operating_profit": -1436046000,
      "revenue": 0,
      "sga_expenses": 1436046000,
      "total_assets": 1476027000,
      "total_equity": -2939914000,
      "total_liabilities": 4415942000
    },
    "2023": {
      "capital_stock": 1727745000,
      "cost_of_sales": 0,
      "current_assets": 552965000,
      "current_liabilities": 3698067000,
      "gross_profit": 0,
      "net_income": -1443976000,
      "net_income_bs": -1443976000,
      "non_current_assets": 909448000,
      "non_current_liabilities": 835176000,
      "non_operating_expenses": 149713000,
      "non_operating_income": 12823000,
      "operating_profit": -1307086000,
      "revenue": 0,
      "sga_expenses": 1307086000,
      "total_assets": 1462413000,
      "total_equity": -3070831000,
      "total_liabilities": 4533244000
    },
    "2024": {
      "capital_stock": 1778333000,
      "cost_of_sales": 0,
      "current_assets": 88755000,
      "current_liabilities": 6517283000,
      "gross_profit": 0,
      "net_income": -3806524000,
      "net_income_bs": -3806524000,
      "non_current_assets": 309859000,
      "non_current_liabilities": 472018000,
      "non_operating_expenses": 753921000,
      "non_operating_income": 77975000,
      "operating_profit": -3130578000,
      "revenue": 0,
      "sga_expenses": 3130578000,
      "total_assets": 398614000,
      "total_equity": -6590686000,
      "total_liabilities": 6989301000
    }
  },
  "industry": "물리, 화학 및 생물학 연구개발업",
  "investment": [
    {
      "amount": "1,100,000,000",
      "changes": "1,100,000,000",
      "date": "2020-12-04"
    },
    {
      "amount": "113,000,000",
      "changes": "113,000,000",
      "date": "2018-04-24"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2015-03-13"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2015-02-27"
    }
  ],
  "main_products": "강아지암치료제,돼지DNA테라피 연구개발",
  "phone": "02-3147-****",
  "years": [
    2024,
    2023,
    2022
  ]
}